Back to News
Market Impact: 0.55

Is Nebius Stock a Buy Now?

NBISMSFTMETAUBER
Artificial IntelligenceTechnology & InnovationCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsCredit & Bond MarketsInvestor Sentiment & PositioningAutomotive & EV
Is Nebius Stock a Buy Now?

Nebius Group reported Q3 sales of $146.1 million, up 355% year-over-year, with a Q3 annualized run rate (ARR) of $551 million and management projecting ARR of $7–9 billion by the end of next year; the company sold out capacity and landed a five-year, $3 billion deal with Meta. Nebius has expanded its data-center power target to 2.5 GW, but funded growth with a $4.3 billion September equity and convertible-note raise (plus a follow-on equity offering), driving debt to over $4 billion and Q3 operating expenses to $276.3 million, resulting in a $130.2 million operating loss; the stock trades at a P/S above 60 after a >200% YTD run. Significant demand and strategic wins suggest material upside, but heavy dilution, ballooning debt and widening losses make the equity high-risk for investors until valuation or balance-sheet pressures ease.

Analysis

Market structure: Winners are hyperscalers (MSFT, META) and GPU/chip suppliers plus data‑center builders who can ramp capacity quickly; Nebius (NBIS) captures outsized pricing power in the near term after selling out capacity and winning multi‑year contracts. Losers are smaller colo/cloud providers and power‑constrained regions as 2.5 GW of planned Nebius capacity (vs original 1 GW) absorbs incremental demand. Cross‑asset: NBIS’s large equity raises and >$4B debt will widen its credit spread, lift equity implied volatility, and put localized upward pressure on power, copper and transformer equipment prices over 12–24 months. Risk assessment: Key tail risks are client concentration (MSFT/META together could represent >30% revenue), failure to bring 2.5 GW online on schedule (operational/power permitting), and refinancing risk if credit markets tighten in the next 12–18 months given negative operating cash flow and rapid debt build. Immediate (days) risk is volatility/IV spikes around fundraising; short term (weeks–months) risk is further equity issuance and margin pressure; long term (quarters–years) executes on ARR guidance (management says $7–9B by end of next year) or falls short, which is binary for valuation. Trade implications: If you want AI exposure, prefer MSFT/META (less balance‑sheet risk) over NBIS; implement a relative trade: long MSFT or META (2–3% portfolio) vs short NBIS (1% notional) to capture secular AI demand without leverage risk. Direct NBIS play only on strict entry triggers: buy size-limited (1–2% portfolio) on a pullback ≥30% or when P/S compresses to ≤25; otherwise express bearish view via 3–6 month NBIS put spreads (cost‑limited). Rotate into chipmakers/hyperscaler capex beneficiaries and underweight speculative infra credits. Contrarian angles: Consensus prices growth as almost certain while underweighting execution and dilution risk — the market may be underpricing a multi‑billion debt refinancing event in 12–18 months. Conversely, the market may be underestimating optionality from Avride/TripleTen but these are currently de‑minimis to NAV; historical cloud cycles show rapid price normalization once capacity catches up (12–24 months), so NBIS upside is high‑beta and highly path dependent. Watch for unintended consequences: aggressive share issuance can permanently impair per‑share economics even if top‑line targets are met.